Ignyta (RXDX) Priced

Clinical-stage biotech developing targeted cancer therapeutics.

Health Care - Biotechnology

IPO Performance
Latest Trade $9.60 0.00 (0.0%)
First Day Return 11.5%
Return from IPO 4.9%
 
Ignyta IPO News more
  • .
IPO Data
IPO File Date 02/28/2014
Offer Price $9.15
Price Range $9.15 - $9.15
Offer Shares (mm) 5.2
Deal Size ($mm) 48
 
IPO Data
IPO Date 03/13/2014
Offer Price $9.15
Price Range $9.15 - $9.15
Offer Shares (mm) 5.2
Deal Size ($mm) $48
 
Underwriters
more
Business Overview
Clinical-stage biotech developing targeted cancer therapeutics.
Clinical-stage biotech developing targeted cancer therapeutics.
more
Company Data
Headquarters San Diego, CA
Founded 2011
Employees 17
Website www.ignyta.com
 

Performance vs. IPO Index (IPOUSA)